Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AZD0530 | FIMM | pan-cancer | AAC | 0.092 | 0.6 |
mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.6 |
mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | 0.031 | 0.6 |
mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.029 | 0.6 |
mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.025 | 0.6 |
mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.6 |
mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.6 |
mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.6 |